Rutgers biomedical engineers have developed a 'bio-ink' for 3D printed materials that could serve as scaffolds for growing human tissues to repair or replace damaged ones in the body. The study was published in the journal Biointerphases.
Safe and environmentally-friendly hydrogen gas on demand could be on the horizon following a new 'hydrogenation' chemical process in development at The City College of New York. Led by Mahesh K. Lakshman, the research uniquely bypasses the need for an external source of hydrogen gas to accomplish a wide range of hydrogenations. It appears as an inside cover feature in the 2020 issue #1 of journal 'Advanced Synthesis and Catalysis.'
Hemp is technically legal in Texas, but proving that hemp is not marijuana can be a hurdle, requiring testing in a licensed laboratory. Now, a team of Texas A&M AgriLife researchers have created a 'hemp scanner' that could easily fit in a police cruiser and distinguish hemp and marijuana instantly, without damaging any of the product.
As the leading cause of mortality worldwide, cardiovascular diseases claim over 17 million lives each year, according to World Health Organization estimates. To open up new research avenues into this serious public health problem, Inserm researcher Nicolas L'Heureux and his team at the Tissue Bioengineering unit (Inserm/Université de Bordeaux) are developing "human textiles" from collagen in order to repair damaged blood vessels. This innovation is now described in the journal Acta Biomaterialia.
A new study shows that just having a parent with an alcohol use disorder affects how your brain transitions between active and resting states -- regardless of your own drinking habits.
Study to be presented at 3rd Global NASH Congress in London, U.K., February 10, 11. Data shows, for the first time, that INDY inhibition attenuates diet-induced NASH and mINDY inhibitors may be a novel therapeutic option. In a murine NASH model, a small molecule INDY inhibitor reduced transaminases, hepatic injury, steatosis and inflammation, and improved glucose metabolism and body composition compared to vehicle-treated mice
Researchers from the University of Tsukuba found that soluble CD155 suppresses NK cells of the innate immune system to promote tumor growth by interfering with DNAM-1. These findings could be exploited to develop novel therapies for cancer by targeting soluble CD155.
The University of Tokyo Institute of Industrial Science researchers modeled the role of hydrodynamics in liquid-liquid transitions of a single-component system. They showed that domain formation is related to the density upon transition, which can be influenced by hydrodynamics. The findings could provide a basis for further investigations into shear flow systems, as well as a means of optimizing industrial applications such as chemical production.
Researchers at Kanazawa University report in the Journal of Thoracic Oncology a promising novel approach for a combined treatment of the most common type of lung cancer and associated secondary cancers in the central nervous system. The approach lies in combining two cancer drugs, with one compensating for a resistance side effect of the other.
Joyce Tait, Founder and co-Director of the Innogen Institute -- a partnership with the University of Edinburgh and The Open University in the United Kingdom to speak during the AAAS 2020 session on 'Synthetic Biology: Digital Design of Living Systems.' She will explore the re-engineering of biological components through computational modelling and bio-systems design technologies and how they will require new frameworks for adaptive and responsible regulation.